Showing results (1-10 of 429) with videos related to

Sort By:
Pageof 43
Patient Preference and Adherence|July 5, 2022
Patient Preference Studies for Advanced Prostate Cancer Treatment Along the Medical Product Life Cycle: Systematic Literature ReviewDominik Menges, Michela C Piatti, Thomas Cerny, et al.
European Urology Open Science|May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice ExperimentDominik Menges, Michela C Piatti, Aurelius Omlin, et al.
Public Health Reviews|April 22, 2024
Emerging Health Care Leaders: Lessons From a Novel Leadership and Community-Building ProgramAndrea Martani, Agne Ulyte, Dominik Menges, et al.
Critical Care (London, England)|January 7, 2021
Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysisDominik Menges, Bianca Seiler, Yuki Tomonaga, et al.
Therapeutic Advances in Chronic Disease|October 11, 2019
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling studyHenock G Yebyo, Hélène E Aschmann, Dominik Menges, et al.
The Lancet. Digital Health|August 28, 2021
Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit-harm modelling studyHenock G Yebyo, Julia Braun, Dominik Menges, et al.
Diagnostic and Prognostic Research|May 12, 2026
Variable selection for prediction models of Omicron infection: Insights from two population-based cohort studiesJoanne Lacy, Dominik Menges, Tala Ballouz, et al.
Plos One|July 12, 2021
Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort studyDominik Menges, Tala Ballouz, Alexia Anagnostopoulos, et al.
Swiss Medical Weekly|January 31, 2022
Early mobilisation and rehabilitation in Swiss intensive care units: a cross-sectional surveyYuki Tomonaga, Dominik Menges, Henock G Yebyo, et al.
Plos One|November 3, 2022
Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancerMichaela C Barbier, Yuki Tomonaga, Dominik Menges, et al.
Pageof 43